https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Canonical and noncanonical inflammasomes in intestinal epithelial cells https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37122 Wed 19 Aug 2020 10:18:44 AEST ]]> Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48579 Tue 21 Mar 2023 17:43:58 AEDT ]]> TRAV26-2 T-Cell Receptor Expression is Associated with Mucosal Lymphocyte Response to Wheat Proteins in Patients with Functional Dyspepsia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54158 Tue 06 Feb 2024 12:17:30 AEDT ]]> IL-6 drives neutrophil-mediated pulmonary inflammation associated with bacteremia in murine models of colitis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34597 Thu 13 Jan 2022 10:31:31 AEDT ]]> Inflammasomes in in the intestinal epithelium https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55944 Thu 11 Jul 2024 10:37:47 AEST ]]> The gut-brain axis in neuropsychopathology https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37534 Thu 04 Feb 2021 16:22:20 AEDT ]]> Bioavailability of arsenic, cadmium, lead and mercury as measured by intestinal permeability https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43435 Papp), with differences in ML retention and complexation amongst the chelants and the gut microbes. The decrease in ML permeability varied amongst the MLs. Chelating agents reduce intestinal absorption of MLs by forming complexes thereby making them less permeable. In the case of gut bacteria, the decrease in the intestinal permeability of MLs may be associated to a direct protection of the intestinal barrier against the MLs or indirect intestinal ML sequestration by the gut bacteria through adsorption on bacterial surface. Thus, both gut microbes and chelating agents can be used to decrease the intestinal permeability of MLs, thereby mitigating their toxicity.]]> Mon 19 Sep 2022 11:35:28 AEST ]]> Isolation and in vitro culture of human gut progenitor cells https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45729 Mon 07 Nov 2022 13:12:39 AEDT ]]> Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49107 Fri 05 May 2023 11:32:08 AEST ]]> A rodent model of anxiety: The effect of perinatal immune challenges on gastrointestinal inflammation and integrity https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36750 Fri 03 Jul 2020 09:05:42 AEST ]]>